BioNTech SE
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.About BNTX
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.
CEOUgur Sahin
CEOUgur Sahin
Employees7,807
Employees7,807
HeadquartersMainz, Rheinland-Pfalz
HeadquartersMainz, Rheinland-Pfalz
Founded2008
Founded2008
Employees7,807
Employees7,807
BNTX Key Statistics
Market cap23.09B
Market cap23.09B
Price-Earnings ratio-11.86
Price-Earnings ratio-11.86
Dividend yield—
Dividend yield—
Average volume1.12M
Average volume1.12M
High today$93.50
High today$93.50
Low today$91.23
Low today$91.23
Open price$93.15
Open price$93.15
Volume172.49K
Volume172.49K
52 Week high$124.00
52 Week high$124.00
52 Week low$79.52
52 Week low$79.52
BNTX News
Simply Wall St 2d
The Bull Case For BioNTech Could Change Following Cut 2026 Guidance And Deeper LossesIn early August 2026, BioNTech SE lowered its 2026 revenue guidance to €1,600 million–€1,900 million and reported second-quarter sales of €105.6 million with a...
Analyst ratings
71%
of 21 ratingsBuy
71.4%
Hold
28.6%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.